Please login to the form below

Not currently logged in
Email:
Password:

I-Mab

This page shows the latest I-Mab news and features for those working in and with pharma, biotech and healthcare.

AbbVie signs immunotherapy pact with I-Mab worth $2bn

AbbVie signs immunotherapy pact with I-Mab worth $2bn

In addition, I-Mab will receive a milestone payment of $20m based on results from phase 1 studies of the drug. ... If the drug proves effective and wins regulatory approval, AbbVie will also pay I-Mab tiered royalties from low-to-mid teen percentages on

Latest news

  • Morphosys’ Darzalex patent challenge hits a hurdle Morphosys’ Darzalex patent challenge hits a hurdle

    China in the first quarter of this year with the help of partner I-Mab, which licensed rights to the drug in mainland China, Hong Kong, Macau and Taiwan in November

  • Biologics at forefront

    anti-IL 21 MAb (autoimmune/inflammatory disease)   . Preclinical . 181.5. Intercell/GSK Biologicals . patch-based vaccines  .  . ... 5m at the start of phase I studies on the IL-21 MAb, plus royalties on net sales.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2016 Deal Watch March 2016

    Acquisition - company. $600. Boehringer Ingelheim/ AbbVie. BI-655066: anti-IL-23 MAb in Phase III for psoriasis and other autoimmune disorders; and BI-655064: anti-CD-40 MAb in Phase I. ... Acquisition – company. $200. TaiMed/ Theratechnologies.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....